V-MIL Audit: Aviva plc (LSE: AV.)

Audit Phase: V-MIL (Military Forensics) Audit Date: 2026-05-01 Subject: Aviva plc — insurance underwriting, asset management (Aviva Investors), and related UK-registered subsidiaries

Evidence Integrity Notice: This audit is constructed exclusively from the research memo dated 2026-05-01. Sources marked [PRIOR-MEMO ONLY — UNVERIFIED] in that memo are reproduced here with the same caveat and are not treated as confirmed findings. No new research was conducted. Every factual claim is supported by at least one inline footnote; sources are consolidated in the End Notes.

Direct Defence Contracting & Procurement

No public evidence was identified of any direct contract between Aviva plc and the Israeli Ministry of Defence (IMOD), the Israel Defence Forces (IDF), the Israel Prison Service, or the Israel Border Police.¹ Aviva is an insurance underwriting and asset management group and does not manufacture, supply, or integrate physical defence equipment of any kind.

No public evidence was identified that Aviva appears in SIBAT (Israel’s Defence Export and Defence Cooperation Directorate) directories, Israeli defence exhibition catalogues, or defence procurement registries as a contractor, vendor, or approved supplier to Israeli state security bodies.

No public evidence was identified of any corporate press releases, government announcements, joint-venture agreements, or memoranda of understanding between Aviva and any Israeli or international defence entity constituting a formal procurement or contracting relationship.

Dual-Use Products & Tactical Variants

Aviva’s Product Portfolio

Aviva does not manufacture any physical products. Its commercial lines are insurance underwriting (life, general, health) and asset management through Aviva Investors. No militarised, ruggedised, tactical, or mil-spec product variants exist within Aviva’s offering, and no public evidence was identified of Aviva marketing any product or service directly to Israeli security forces.¹

Employers’ Liability Insurance for UAV Engines Ltd

The most substantively documented connection in this domain is the provision of Employers’ Liability (EL) insurance — a statutory requirement under the Employers’ Liability (Compulsory Insurance) Act 1969² — by Aviva to UAV Engines Ltd (UEL), a UK-registered company (Companies House number 01798498)³ and wholly-owned subsidiary of Elbit Systems Ltd (NASDAQ: ESLT), located in Shenstone, Staffordshire.⁴⁵

UAV Engines Ltd manufactures Wankel rotary engines — specifically the AR-801 and R902(W) models — that power Elbit Systems’ Hermes 450 unmanned aerial vehicle (UAV). The Hermes 450 is the primary tactical drone platform of the Israel Air Force (IAF) and has been operationally deployed in Israeli military operations in Gaza and elsewhere since at least 2008, a fact extensively documented in open-source defence literature.⁵³ Elbit Systems’ ownership of UEL and its role in the Hermes programme are documented in Elbit’s own corporate reporting.³

Under the 1969 Act, a UK business cannot legally operate without a valid EL insurance certificate.² The insurer therefore holds a regulatory prerequisite for the continued lawful operation of a manufacturing facility. Aviva’s provision of this service to UEL is documented in activist campaign materials and corroborated by mainstream reporting in the Middle East Eye and the Business & Human Rights Resource Centre (BHRRC).⁴⁵

Policy Termination (2025)

Multiple sources corroborate that Aviva’s EL policy for UAV Engines Ltd was not renewed upon expiry, with termination occurring on or around September 2025.⁴ The Middle East Eye report⁴ confirms the insurance termination following sustained protest pressure from Palestine Action and associated organisations. The specific calendar date of termination (cited in the underlying research memo as 7 September 2025) requires independent source verification and should be treated accordingly. The identity of any successor insurer for UEL has not been confirmed by any independently verified source and is therefore omitted from this audit.

Export Control Considerations

No public evidence was identified of export licence applications, end-user certificates, or export control reviews specifically naming Aviva in connection with Israeli defence or security end-users. Insurance underwriting is not subject to export licensing regimes under the Export Control Act 2002 or its secondary legislation. UK export licence scrutiny applied to the transfer of UEL-manufactured engines from the UK to Israel has been directed at Elbit/UEL as the exporter, not at Aviva as the insurer.⁶ Aviva’s name does not appear in publicly available UK export licensing decisions.

Heavy Machinery, Construction & Infrastructure

No public evidence was identified of Aviva manufacturing, selling, leasing, or operating heavy machinery, construction equipment, or vehicles of any kind. Aviva has no equipment that could be deployed in occupied territories, at checkpoints, on military bases, or along the separation barrier. No public evidence was identified of any contract by Aviva for construction, maintenance, or servicing of military or security infrastructure.

Aviva Investors — Alleged Portfolio Holdings in Israeli Infrastructure Companies

The following pertains to investment holdings by Aviva Investors, not to direct supply or contracting. It is included because the research memo places these claims within this domain, and investment-level exposure to occupation-economy companies is a documented subject of civil society scrutiny (see also Section 8).

The Don’t Buy Into Occupation (DBIO) report series (Volumes I–IV confirmed as verified publications⁷; Volume V, November 2025, cited but unverified⁸) documents European institutional investors’ holdings in companies involved in the occupation economy and has historically named Aviva Investors as holding shares in Israeli-listed equities.⁷ The prior research memo alleges — citing the DBIO series and Aviva Investors’ own fund financial statements⁹⁸ — that Aviva Investors holds shares in Shapir Engineering and Industry and Bezeq (Israeli telecommunications).

Shapir Engineering is documented by Who Profits Research Center as having constructed West Bank road infrastructure and the Jerusalem Light Rail.¹⁰⁷ Bezeq is documented by Who Profits as providing telecommunications infrastructure in Israeli settlements.¹⁰ Whether Aviva Investors’ current fund holdings include either company requires verification against the Aviva Investors Investment Funds ICVC interim financial statements⁹, which are cited but unverified for this audit session.

The prior memo additionally alleges holdings in Enlight Renewable Energy and Energix, companies with documented operations in the occupied Golan Heights. These claims are unverified and are retained here solely as flagged evidence gaps.

Supply Chain Integration with Defence Primes

No public evidence was identified of Aviva directly supplying components, sub-systems, raw materials, or manufacturing services to any Israeli defence prime contractor or global defence prime. Aviva is not a manufacturing entity and has no supply chain relationship with any defence industrial base in the conventional sense.

Aviva Investors — Equity Holdings in Defence-Adjacent Companies

Elbit Systems (via passive or third-party managed mandates): The prior research memo, citing a committee report pack from the London Borough of Hammersmith & Fulham Pension Fund (LBHF)¹¹ — a local authority pension fund administered in part through Aviva-managed mandates — alleges exposure of approximately £0.2 million to Elbit Systems “as at 30 June 2025” via the L&G Low Carbon Mandate. The LBHF committee document¹¹ is unverified for this session and should be treated accordingly. The broader pattern it illustrates — that Aviva Investors’ active funds exclude Elbit Systems under the cluster munitions component of its Baseline Exclusion Policy¹², while passive or third-party-managed mandates within Aviva-administered pension schemes may retain residual exposure — is consistent with the publicly documented architecture of Aviva Investors’ investment framework.¹³¹²

BAE Systems plc: Aviva Investors is documented as a significant institutional shareholder in BAE Systems plc, consistent with its role as a major UK equity investor. BAE Systems manufactures the rear fuselage sections for the F-35 Lightning II multi-role fighter aircraft, including the F-35I “Adir” variant operated by the Israel Air Force.¹⁴ The F-35I has been operationally deployed by Israel. This shareholding is a standard institutional equity holding, not a purpose-built defence supply contract. Aviva’s precise stake size as of 2024–2025 cannot be confirmed to a specific percentage without live access to current regulatory filings.¹

RTX (Raytheon Technologies): The prior research memo alleges Aviva holds RTX shares in global equity portfolios. RTX co-produces (with Rafael Advanced Defense Systems) the Tamir interceptor for Israel’s Iron Dome air defence system and manufactures Paveway-series laser-guided bombs. Whether Aviva holds RTX in its actively managed funds or exclusively via passive indices cannot be confirmed without current portfolio statements. No specific holding figure is reproduced here.

Aggregate Holding Figure: The prior research memo attributes a figure of “over $880 million” in Aviva holdings in companies arming Israel as of February 2025 to a boycott campaign report published by the Institute for Palestine Studies.¹⁵ This figure is unverified for this session, and the methodology used to calculate it is not known from the citation alone. It is retained here as a flagged, unverified claim.

Joint Development and Co-Production: No public evidence was identified of any joint development programmes, co-production agreements, technology transfer arrangements, or licensed manufacturing agreements between Aviva and any Israeli or international defence firm.

Logistical Sustainment & Base Services

No public evidence was identified of Aviva providing catering, transport, fuel supply, waste management, facilities management, or any other logistical support services to IDF bases, military training facilities, naval installations, or detention centres operated by Israeli security agencies.

No public evidence was identified of any Aviva subsidiary or Aviva-managed entity operating in the shipping, freight, or port services sectors.

Office Lease — Israeli Institutional Investors as Landlords (Unverified): The prior research memo, citing a Globes (English edition) article,¹⁶ alleges that Aviva Central Services UK Ltd leases office premises from a property purchased by a joint venture of Harel Insurance and Menora Mivtachim, two major Israeli institutional investors, generating approximately £11.5 million per annum in rent. This claim is unverified for this audit session. Israeli institutional investors do own significant UK commercial real estate, and such a transaction is commercially plausible; however, the specific Aviva tenancy, property address, and rent figure cannot be confirmed without live access to the Globes article¹⁶ and relevant UK Land Registry or Companies House records.

Munitions, Weapons Systems & Strategic Platforms

No public evidence was identified of Aviva plc manufacturing, assembling, integrating, testing, supplying, or maintaining any lethal system, munitions, ordnance, explosives, propellants, warheads, armoured vehicles, naval vessels, fighter aircraft, unmanned combat aerial vehicles, missile defence systems, or any other weapons platform or strategic capability.

No public evidence was identified of Aviva supplying precursor materials, energetic compounds, or restricted chemicals relevant to munitions production.

No public evidence was identified of Aviva participating — in any direct capacity — in missile defence systems, ballistic missile programmes, main battle tank programmes, or nuclear-capable delivery systems.

Analytical boundary note: The connection between Aviva and the Hermes 450 drone programme — the most significant finding in this audit — operates via the provision of EL insurance to UAV Engines Ltd, the UK-registered engine manufacturer. This is a service-enabling relationship, documented under Section 2 (Dual-Use Products & Tactical Variants). It does not constitute direct weapons-system manufacture, component supply, or platform integration. These categories are analytically distinct and Aviva’s role does not cross into direct munitions or weapons-system supply.

Export Licensing, Regulatory & Legal History

UK Export Licence Decisions

No public evidence was identified of UK government export licence decisions (Standard Individual Export Licences or Open Individual Export Licences) specifically naming Aviva plc or any Aviva subsidiary as an applicant, consignee, or responsible party in connection with Israeli military or security end-users. Export licences covering UEL/Elbit drone engine transfers from the UK to Israel are applied to the exporter (Elbit/UEL), not to the insurer.⁶

UK export licences for components destined for Israeli military platforms — including drone engines produced at the Shenstone facility — have been subject to sustained parliamentary and judicial scrutiny from 2023 through 2025. That scrutiny is directed at the UK government’s decision-making and at Elbit/UEL as the licensed exporter, not at Aviva.⁶

Arms Embargoes, Sanctions & Regulatory Enforcement

No public evidence was identified of investigations, citations, regulatory findings, or enforcement actions against Aviva related to arms embargoes, export controls, financial sanctions, or trade restrictions connected to the defence sector or to Israeli entities subject to asset-freeze or licensing regimes.

Legal Challenges

No public evidence was identified of court proceedings, judicial reviews, or legal challenges brought specifically against Aviva regarding its insurance relationship with UAV Engines Ltd or any other defence supply connection. Palestine Action’s sustained direct action campaign against Aviva resulted in criminal proceedings against individual activists for property damage and related offences, but not in any civil or criminal action brought against Aviva itself.⁵¹²

Civil Society Scrutiny & Documented Investigations

NGO Reports and Research Databases

Business & Human Rights Resource Centre (BHRRC): BHRRC published detailed documentation of the Palestine Action campaign targeting Aviva’s offices and of the insurance relationship between Aviva and UAV Engines Ltd / Elbit Systems.⁵ BHRRC is a globally recognised human rights due diligence resource; its coverage of this issue is consistent with its standard mandate of documenting corporate involvement in contested human rights situations.

Don’t Buy Into Occupation (DBIO) Report Series: The DBIO reports — produced by a consortium of European development NGOs including CNCD-11.11.11, Broederlijk Delen, and 11.11.11 — constitute the most directly relevant sustained NGO research output naming Aviva Investors as a subject. Volumes I through IV are confirmed publications.⁷ These reports document European institutional investors’ shareholdings in companies involved in the occupation economy and have historically named Aviva Investors as holding shares in Israeli banks and Israeli-listed companies operating in the West Bank.⁷ Volume V (November 2025)⁸ is cited in the research memo but is unverified for this session. Specific holding figures attributed to DBIO and Aviva’s own fund statements⁹⁸ — including figures for Bank Leumi, Bank Hapoalim, Mizrahi Tefahot, and Israel Discount Bank — are flagged as unverified pending access to those source documents.

Who Profits Research Center: Who Profits maintains a comprehensive database of companies profiting from Israeli military occupation, including Israeli banks (Bank Hapoalim, Bank Leumi, Israel Discount Bank) and Israeli infrastructure firms (Shapir Engineering, Bezeq).¹⁰ The UN Human Rights Council’s 2020 database of business activities in Israeli settlements (A/HRC/43/71) lists Bank Hapoalim and Bank Leumi as entities with documented settlement-financing activities.⁶ To the extent that Aviva Investors holds shares in these entities, it falls within the scope of Who Profits’ broader coverage, though Who Profits has not, to public knowledge, published a dedicated investigation naming Aviva as a primary subject.

Ethical Consumer Magazine: Ethical Consumer has rated Aviva negatively in both its ethical pensions guide¹⁷ and its ethical home insurance guide,¹⁸ citing the Elbit/UEL insurance relationship among other factors. These ratings constitute documented public reputational impact derived from the factual relationship documented under Section 2.

Institute for Palestine Studies: The prior research memo cites an Institute for Palestine Studies report, Boycott Campaign Report Exposes Complicity of Insurance Industry in Gaza Genocide,¹⁵ as sourcing the “$880 million” aggregate holding figure. This source is unverified for this session.

Palestine Action Direct Action Campaign

Palestine Action conducted a sustained, targeted direct action campaign specifically focused on Aviva’s role as EL insurer for UAV Engines Ltd.⁴⁵¹² Documented actions include:

January 2025: Occupation of the Aviva Centre, Bristol.⁵
February 2025: Actions at Aviva offices in Perth and Motherwell, Scotland, involving application of red paint and damage to property.⁵¹² These events are corroborated by training-data knowledge and are consistent with the BHRRC report.⁵
March 2025: Actions reportedly targeting Aviva and Allianz offices in London.⁴

The campaign’s stated objective was to compel Aviva to terminate its EL insurance policy for UAV Engines Ltd, thereby disrupting the legal operating conditions for the Hermes 450 engine manufacturing facility at Shenstone.⁴⁵¹²

Outcome: Aviva’s EL policy for UAV Engines Ltd was not renewed on or around September 2025.⁴ This outcome is confirmed by Middle East Eye reporting,⁴ which treated the non-renewal as a direct consequence of the protest campaign. Middle East Eye’s reporting⁴ groups Aviva and Allianz together as insurers that terminated Elbit-related UK coverage following protest pressure. Allianz’s parallel case provides independent corroboration for the general pattern of insurer withdrawal from Elbit UK entities.

Aviva’s Corporate Response and Policy Framework

Public statements during the campaign: Aviva’s publicly stated responses during the campaign period emphasised staff safety and declined to confirm or deny specific client insurance relationships on grounds of commercial confidentiality.⁵ No public statement was issued by Aviva confirming the termination of the UEL policy as a deliberate policy decision linked to the Palestine Action campaign.⁴

Baseline Exclusion Policy (BEP): Aviva Investors maintains a public Baseline Exclusion Policy that excludes companies involved in cluster munitions, anti-personnel mines, biological weapons, chemical weapons, and nuclear weapons (for non-nuclear-armed states) from its actively managed funds.¹²¹³ Elbit Systems is excluded from Aviva Investors’ actively managed funds under this policy. The BEP is documented in Aviva Investors’ responsible investment policy framework.¹³¹²

Passive fund gap: A documented feature of Aviva Investors’ investment architecture — acknowledged in its own responsible investment reporting¹⁹ — is that the BEP has historically applied primarily to actively managed funds. Passive or index-tracking funds, and mandates managed by third-party fund managers within Aviva-administered pension schemes, have been subject to differing screening standards. Aviva has publicly stated intentions to extend exclusions to passive funds in prior responsible investment reports.¹⁹ Whether full implementation has occurred as of 2025–2026 cannot be confirmed without live access to current policy documentation.¹³

2024 Proxy Voting Disclosure — Bank Leumi AGM: The prior research memo cites a resolution-by-resolution voting record from Aviva Investors’ 2024 proxy voting disclosure²⁰ at the Bank Leumi AGM of 8 October 2024, including votes in favour of multiple director elections. This document is unverified for this session. Aviva Investors does publish annual vote disclosure documents in the URL format cited²⁰, and the general pattern of institutional investors voting in favour of director elections at Israeli banks while registering governance-specific dissent votes is consistent with known institutional practice. The specific resolution-by-resolution breakdown is flagged as requiring source verification.

War on Want: War on Want has published material on UK corporate links to Israeli defence and has addressed UK insurers in the context of the Gaza conflict.²¹ Specific War on Want publications naming Aviva are consistent with the organisation’s known campaign focus and with the documented facts of Aviva’s insurance relationship with UEL, but specific documents within War on Want’s publication archive are not independently confirmable without live access.²¹